Your browser doesn't support javascript.
loading
Immune Characterization of the Programmed Death Receptor Pathway in High Risk Prostate Cancer.
Baas, Wesley; Gershburg, Svetlana; Dynda, Danuta; Delfino, Kristin; Robinson, Kathy; Nie, Daotai; Yearley, Jennifer Holmes; Alanee, Shaheen.
Afiliação
  • Baas W; Division of Urology, Southern Illinois University School of Medicine, Springfield, IL.
  • Gershburg S; Center for Clinical Research, Southern Illinois University School of Medicine, Springfield, IL.
  • Dynda D; Division of Urology, Southern Illinois University School of Medicine, Springfield, IL.
  • Delfino K; Center for Clinical Research, Southern Illinois University School of Medicine, Springfield, IL.
  • Robinson K; Cancer Institute, Southern Illinois University School of Medicine, Springfield, IL.
  • Nie D; Department of Med Micro, Immunology, and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL.
  • Yearley JH; Merck Research Laboratories, Palo Alto, CA.
  • Alanee S; Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. Electronic address: salanee1@hfhs.org.
Clin Genitourin Cancer ; 15(5): 577-581, 2017 10.
Article em En | MEDLINE | ID: mdl-28461179
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Linfócitos T / Regulação para Baixo / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Linfócitos T / Regulação para Baixo / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Idioma: En Ano de publicação: 2017 Tipo de documento: Article